Drug recall · June 17, 2020
Ketorolac Tromethamine Injection recall
Why: Presence of Particulate Matter - found in reserve sample vials at the firm.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.
- Lots / codes
Lot #: 6118737, 6118902, Exp 04/2020; 6119052, Exp 05/2020; 6119752, Exp 08/2020; 6122349, Exp 07/2021; 6122538, Exp 09/2021
- Quantity
- 5,314,400 vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- USA Nationwide and Puerto Rico
- Initiated
- April 20, 2020 · Voluntary: Firm initiated
- Classified
- June 8, 2020
- Reported
- June 17, 2020
- Ended
- October 16, 2023
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ketorolac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.